Workflow
SIRIO(300791)
icon
Search documents
仙乐健康(300791) - 关于选举职工代表董事的公告
2025-08-04 09:44
| 证券代码:300791 | 证券简称:仙乐健康 | 公告编码:2025-078 | | --- | --- | --- | | 债券代码:123113 | 债券简称:仙乐转债 | | 仙乐健康科技股份有限公司 仙乐健康科技股份有限公司 一、职工代表董事选举情况 为进一步完善公司治理结构,根据《中华人民共和国公司法》和《仙乐健康 科技股份有限公司章程》(以下简称"《公司章程》")的规定,仙乐健康科技 股份有限公司(以下简称"公司")于 2025 年 8 月 4 日召开第三届职工代表大 会第六次会议,经与会职工代表审议,选举赵酉酉女士(简历附后)为公司第四 届董事会职工代表董事,任期自本次职工代表大会审议通过之日起至公司第四届 董事会任期届满之日止。 赵酉酉女士符合相关法律法规、规范性文件及《公司章程》有关董事任职的 资格和条件。本次选举完成后,公司第四届董事会中兼任公司高级管理人员以及 由职工代表担任的董事总计不超过公司董事人数总数的二分之一,符合相关法律 法规的要求。 二、备查文件 1、仙乐健康科技股份有限公司第三届职工代表大会第六次会议决议。 特此公告。 关于选举职工代表董事的公告 本公司及董事会全体成 ...
仙乐健康(300791) - 2025年第三次临时股东大会决议公告
2025-08-04 09:44
证券代码:300791 证券简称:仙乐健康 公告编码:2025-076 债券代码:123113 债券简称:仙乐转债 仙乐健康科技股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 特别提示: 1、本次股东大会未出现增加、否决或变更议案的情形; 6、会议的召集、召开与表决程序符合《中华人民共和国公司法》、《深 圳证券交易所创业板股票上市规则》、《深圳证券交易所上市公司自律监管 指引第 2 号——创业板上市公司规范运作》等法律、法规及规范性文件以及 1 《仙乐健康科技股份有限公司章程》的相关规定。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、 会议召开情况 1、现场会议召开时间:2025 年 8 月 4 日(星期一)下午 15:00 2、现场会议召开地点:汕头市龙湖区泰山路 83 号公司行政楼会议室, 公司现场会议同时提供了远程视频参会系统。 3、网络投票时间:2025 年 8 月 4 日 其中,通过深圳证券交易所交易系统进行网络投票的具体时间为:2025 年 8 月 4 日 9:15-9:25,9: ...
仙乐健康(300791) - 关于离任董监高持股及减持承诺事项说明的公告
2025-08-04 09:44
一、基本情况 | 证券代码:300791 | 证券简称:仙乐健康 | 公告编码:2025-077 | | --- | --- | --- | | 债券代码:123113 | 债券简称:仙乐转债 | | 仙乐健康科技股份有限公司 关于离任董监高持股及减持承诺事项说明的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 仙乐健康科技股份有限公司(以下简称"公司")于 2025 年 8 月 4 日召开 2025 年第三次临时股东大会,审议通过了《关于变更公司注册资本及修订〈公司 章程〉的议案》,根据《中华人民共和国公司法(2023 年修订)》《上市公司章 程指引(2025 年修订)》《深圳证券交易所创业板股票上市规则》《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律法规、 规范性文件的最新要求及公司总股本和注册资本的变更情况,结合公司实际,对 《公司章程》进行修订和完善。《公司章程》修订后,公司不再设置监事会,《公 司法》规定的监事会的职权由董事会审计委员会行使,现任监事不再担任监事职 务。 公司现任监事谢盈瑜女士、张美彬先生、朱 ...
仙乐健康(300791) - 广东信达律师事务所关于仙乐健康2025年第三次临时股东大会的法律意见书
2025-08-04 09:44
法律意见书 信达会字(2025)第233号 广东信达律师事务所 股东大会法律意见书 中国深圳福田区益田路 6001 号太平金融大厦 11 楼、12 楼 邮政编码:518038 11、12/F, TaiPingFiance Tower,Yitian Road 6001,Futian District, ShenZhen, P. R. China 电话(Tel.):(0755) 88265288 传真(Fax.):(0755)88265537 网址(Website):https://www.sundiallawfirm.com 广东信达律师事务所 关于仙乐健康科技股份有限公司 2025年第三次临时股东大会的 致:仙乐健康科技股份有限公司(下称"贵公司") 广东信达律师事务所接受贵公司的委托,指派高灵灵律师及万茜律师(下称 "本所律师")参加了贵公司2025年第三次临时股东大会(下称"本次股东大会"), 并进行了必要的验证工作。现根据《中华人民共和国公司法》(下称"《公司法》")、 《上市公司股东会规则》(下称"《股东会规则》")、《深圳证券交易所上市 公司股东会网络投票实施细则》(下称"《网络投票实施细则》")等 ...
食品饮料周观点:育儿补贴政策落地,推新积极挖掘增量-20250803
GOLDEN SUN SECURITIES· 2025-08-03 10:36
Investment Rating - The report maintains an "Increase" rating for the food and beverage industry, indicating a positive outlook for the sector [5]. Core Insights - The implementation of the childcare subsidy policy is expected to stimulate growth in the food and beverage sector, particularly benefiting the infant formula and dairy product markets [4]. - The report highlights three main investment themes in the liquor segment: strong leading brands, sustained regional advantages, and recovery-driven elastic stocks [1][2]. - In the beer and beverage segment, Budweiser faces sales pressure but is seeing price recovery, while the sugary tea category is gaining market share during peak seasons [3]. Summary by Sections Liquor Industry - Leading brands such as Moutai, Wuliangye, and Luzhou Laojiao dominate the global rankings, with Moutai valued at $58.4 billion, maintaining its position as the most valuable liquor brand globally [2]. - The liquor sector is transitioning from scale growth to high-quality development, with a focus on brand strength and market positioning [2]. Beer and Beverage Sector - Budweiser's Q2 2025 results show a revenue decline of 3.9% and a profit drop of 31.1%, with a notable 6.2% decrease in sales volume [3]. - The sugary tea segment is experiencing a resurgence, with brands like Kang Shifu and Uni-President maintaining leading positions, and sales of Yuanqi Forest's iced tea growing by 53.9% year-on-year [3]. Food Sector - The national childcare subsidy program, effective from January 1, 2025, is projected to enhance birth rates and subsequently increase demand for dairy products [4]. - New product launches by companies like Qiaqia and Ximai are aimed at expanding market presence and tapping into health-oriented consumer trends [4][7].
食品加工板块8月1日涨1.17%,*ST春天领涨,主力资金净流出1820.73万元
Market Overview - On August 1, the food processing sector rose by 1.17%, led by *ST Chuntian, while the Shanghai Composite Index closed at 3559.95, down 0.37% [1] - The Shenzhen Component Index closed at 10991.32, down 0.17% [1] Stock Performance - The top performers in the food processing sector included: - *ST Chuntian: Closed at 4.37, up 3.31% with a trading volume of 89,400 shares and a turnover of 38.61 million yuan [1] - Baba Food: Closed at 19.25, up 3.00% with a trading volume of 52,400 shares and a turnover of 100 million yuan [1] - Jinzi Ham: Closed at 6.72, up 2.28% with a trading volume of 404,000 shares and a turnover of 272 million yuan [1] Capital Flow - The food processing sector experienced a net outflow of 18.21 million yuan from institutional investors and 53.49 million yuan from speculative funds, while retail investors saw a net inflow of 71.69 million yuan [2] - Notable capital flows for specific stocks included: - Jinzi Ham: Net inflow of 40.46 million yuan from institutional investors, but a net outflow of 3.79 million yuan from speculative funds [3] - Baba Food: Net inflow of 8.31 million yuan from institutional investors, with a net outflow of 5.63 million yuan from speculative funds [3]
仙乐健康: 关于不向下修正仙乐转债转股价格的公告
Zheng Quan Zhi Xing· 2025-07-30 16:25
Core Viewpoint - The company has decided not to exercise the right to adjust the conversion price of its convertible bonds, "Xianle Convertible Bonds," despite meeting the conditions for downward adjustment, in order to protect the interests of all investors [10]. Group 1: Convertible Bond Issuance - The company issued 10.2489 million convertible bonds with a total fundraising amount of RMB 1,024.8929 million, netting RMB 1,016.1675 million after expenses [1]. - The bonds were listed on the Shenzhen Stock Exchange on May 14, 2021, under the name "Xianle Convertible Bonds" and code "123113" [2]. - The conversion period for the bonds began on October 25, 2021, following the end of the bond issuance [2]. Group 2: Conversion Price Adjustment - The conversion price was initially set at RMB 85.98 per share and was adjusted to RMB 56.92 per share after a cash dividend and capital increase [2][3]. - Subsequent adjustments to the conversion price occurred on several occasions, with the latest adjustment reducing the price to RMB 31.82 per share effective May 27, 2025 [8]. - The company has the authority to propose a downward adjustment of the conversion price if the stock price falls below 85% of the conversion price for at least 15 trading days within a 30-day period [9]. Group 3: Board Decisions - The company's board of directors convened on July 30, 2025, and decided not to propose a downward adjustment of the conversion price for the next six months, even if the conditions for adjustment are met again [10]. - This decision was made to maintain investor confidence and protect the interests of all stakeholders [10].
仙乐健康:关于不向下修正“仙乐转债”转股价格的公告
Zheng Quan Ri Bao· 2025-07-30 13:14
Group 1 - The core point of the article is that Xianle Health announced it will not exercise the downward adjustment of the conversion price for its convertible bonds, despite triggering the conditions for such an adjustment [2] - As of July 30, 2025, the company's stock has been below 85% of the conversion price for at least 15 out of the last 30 trading days, triggering the downward adjustment clause for the Xianle convertible bonds [2] - The company's board of directors decided not to propose a downward adjustment plan for the next six months, from July 31, 2025, to January 30, 2026, even if the conditions are triggered again [2]
仙乐健康:7月30日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-07-30 10:06
Group 1 - The company, Xianle Health, announced that its fourth board meeting was held on July 30, 2025, via teleconference, where it reviewed the proposal regarding not adjusting the conversion price of "Xianle Convertible Bonds" [2] - For the year 2024, the revenue composition of Xianle Health is as follows: soft capsules accounted for 47.1%, gummies for 23.63%, tablets for 7.73%, functional beverages for 5.89%, powders for 5.5%, and hard capsules for 5.29% [2]
仙乐健康(300791) - 关于不向下修正仙乐转债转股价格的公告
2025-07-30 09:30
| 证券代码:300791 | 证券简称:仙乐健康 | 公告编码:2025-075 | | --- | --- | --- | | 债券代码:123113 | 债券简称:仙乐转债 | | 仙乐健康科技股份有限公司 关于不向下修正"仙乐转债"转股价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 特别提示: 1、截至 2025 年 7 月 30 日,仙乐健康科技股份有限公司(以下简称"公司") 股票已经出现在任意连续三十个交易日中至少有十五个交易日的收盘价低于"仙 乐转债"当期转股价格的 85%的情形,触及"仙乐转债"转股价格向下修正条款。 2、经公司第四届董事会第十二次会议审议通过,公司董事会决定本次不行 使"仙乐转债"的转股价格向下修正的权利,且在未来六个月内(即 2025 年 7 月 31 日至 2026 年 1 月 30 日),如再次触发"仙乐转债"转股价格向下修正条 款,亦不提出向下修正方案。 公司于 2025 年 7 月 30 日召开了第四届董事会第十二次会议,审议通过了 《关于不向下修正"仙乐转债"转股价格的议案》,公司董事会决定本次不行使 ...